Hutchmed Drc Stock Performance
| HCM Stock | USD 17.13 0.57 3.44% |
On a scale of 0 to 100, HUTCHMED DRC holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of 1.49, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, HUTCHMED DRC will likely underperform. Please check HUTCHMED DRC's expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether HUTCHMED DRC's current trending patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in HUTCHMED DRC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, HUTCHMED DRC displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 3.44 | Five Day Return 7.4 | Year To Date Return 13.59 | Ten Year Return 26.89 | All Time Return 26.89 |
Last Split Factor 1:1 | Last Split Date 2019-05-30 |
1 | HUTCHMED Completes Enrollment for Phase II Trial of Savolitinib in Gastric Cancer HCM stock news | 04/22/2025 |
2 | HUTCHMED Cut to Hold at StockNews.com | 05/16/2025 |
3 | HUTCHMEDs Phase III SACHI Study Shows Promising Results for Lung Cancer Treatment HCM stock news | 06/02/2025 |
4 | HUTCHMED Ltd Stock Price Up 3.26 percent on Jun 9 | 06/09/2025 |
5 | HUTCHMED Ltd Shares Up 3.91 percent on Jun 12 | 06/12/2025 |
6 | Brandon Hall Group Relaunches TotalTech Platform to Simplify HCM Technology Selection for Global Organizations | 06/16/2025 |
7 | isolved Honors Top-Performing Partners at Inaugural Connect for Partners Event | 06/17/2025 |
8 | HUTCHMED Ltd Stock Price Down 4.41 percent on Jun 20 | 06/20/2025 |
9 | AllianceHCM Appoints Alan Primeaux as Chief Executive Officer to Propel Next Phase of Growth | 06/24/2025 |
10 | HUTCHMED Ltd Gains Approval for New Lung Cancer Treatment in China HCM stock news | 06/30/2025 |
11 | Semos Cloud Named Workday Innovation Partner | 07/02/2025 |
12 | HUTCHMED to Announce 2025 Half-Year Financial Results HCM Stock News | 07/03/2025 |
13 | Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 | 07/10/2025 |
| Begin Period Cash Flow | 283.6 M |
HUTCHMED DRC Relative Risk vs. Return Landscape
If you would invest 1,389 in HUTCHMED DRC on April 18, 2025 and sell it today you would earn a total of 324.00 from holding HUTCHMED DRC or generate 23.33% return on investment over 90 days. HUTCHMED DRC is generating 0.4017% of daily returns assuming volatility of 3.2649% on return distribution over 90 days investment horizon. In other words, 29% of stocks are less volatile than HUTCHMED, and above 92% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
HUTCHMED DRC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HUTCHMED DRC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HUTCHMED DRC, and traders can use it to determine the average amount a HUTCHMED DRC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.123
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | HCM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.26 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.4 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average HUTCHMED DRC is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HUTCHMED DRC by adding it to a well-diversified portfolio.
HUTCHMED DRC Fundamentals Growth
HUTCHMED Stock prices reflect investors' perceptions of the future prospects and financial health of HUTCHMED DRC, and HUTCHMED DRC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HUTCHMED Stock performance.
| Return On Equity | 0.0504 | ||||
| Return On Asset | -0.0214 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 2.01 B | ||||
| Shares Outstanding | 171.08 M | ||||
| Price To Earning | 335.94 X | ||||
| Price To Book | 3.65 X | ||||
| Price To Sales | 4.50 X | ||||
| Revenue | 630.2 M | ||||
| Gross Profit | 69.21 M | ||||
| EBITDA | 14.11 M | ||||
| Net Income | 37.73 M | ||||
| Cash And Equivalents | 829.71 M | ||||
| Cash Per Share | 4.91 X | ||||
| Total Debt | 89.82 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 0.89 X | ||||
| Cash Flow From Operations | 497 K | ||||
| Earnings Per Share | 0.20 X | ||||
| Market Capitalization | 2.83 B | ||||
| Total Asset | 1.27 B | ||||
| Retained Earnings | (833.17 M) | ||||
| Working Capital | 689.99 M | ||||
| Current Asset | 187.47 M | ||||
| Current Liabilities | 96.7 M | ||||
About HUTCHMED DRC Performance
By examining HUTCHMED DRC's fundamental ratios, stakeholders can obtain critical insights into HUTCHMED DRC's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that HUTCHMED DRC is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 52.73 | 93.13 | |
| Return On Tangible Assets | 0.06 | 0.06 | |
| Return On Capital Employed | (0.05) | (0.05) | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.05 | 0.05 |
Things to note about HUTCHMED DRC performance evaluation
Checking the ongoing alerts about HUTCHMED DRC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HUTCHMED DRC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HUTCHMED DRC had very high historical volatility over the last 90 days | |
| Latest headline from finance.yahoo.com: Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 |
- Analyzing HUTCHMED DRC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HUTCHMED DRC's stock is overvalued or undervalued compared to its peers.
- Examining HUTCHMED DRC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HUTCHMED DRC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HUTCHMED DRC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HUTCHMED DRC's stock. These opinions can provide insight into HUTCHMED DRC's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share 0.2 | Revenue Per Share | Quarterly Revenue Growth 0.064 | Return On Assets |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.